Skip to content

effect of pregabalin in attenuation of laryngoscopic responses in patient undergoing general anaesthesia

Evaluation of the effect of oral Pregabalin (150mg) premedication in attenuation of hemodynamic responses to laryngoscopy and intubation in patients undergoing general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054185
Enrollment
80
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H953- Accidental puncture and lacerationof ear and mastoid process during a procedure Health Condition 3: K352- Acute appendicitis with generalized peritonitis Health Condition 4: K801- Calculus of gallbladder with othercholecystitis Health Condition 5: S420- Fracture of clavicle Health Condition 6: O- Medical and Surgical Health Condition 7: H708- Other mastoiditis and related conditions Health Condition 8: N390- Urinary tract infection, site notspecif

Interventions

Intervention1: oral pregabalin: pregabalin - 150 mg by oral route 90 minutes before induction in patient udergoing general anaesthesia Control Intervention1: nil: nil

Sponsors

Pacific Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients giving valid informed consent. Patients aged 18 - 60 years. Patients weighing 50-80 kgs. Patients belonging to ASA (American society of anesthesiologist) physical status Grade I and II.

Exclusion criteria

Exclusion criteria: Patient refusal Patient with ASA grade III or higher Pregnant or lactating woman. On treatment with sedatives, hypnotics, antidepressants, antipsychotic medications. Patients allergic to anaesthetic medications. History of hepatic, renal dysfunction and Ischaemic heart disease. Anticipated difficult intubation Patients weighing less than 50 kgs and more than 80 kgs.

Design outcomes

Primary

MeasureTime frame
Attenuation of hemodynamic response associated with laryngoscopy & intubation. Better analgesia. Timepoint: 24months

Secondary

MeasureTime frame
Better sedation. Absence of serious side effects, if any. Timepoint: 24months

Countries

India

Contacts

Public ContactDr Saloni Agrawal

Pacific Medical College And Hospital

saloniagrawal@ymail.com9408594960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026